Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
25.26
+1.30 (5.43%)
At close: May 12, 2025, 4:00 PM
25.17
-0.09 (-0.36%)
After-hours: May 12, 2025, 5:58 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $18.76 billion as of May 12, 2025. Its market cap has increased by 644.70% in one year.
Market Cap
18.76B
Enterprise Value
18.40B
1-Year Change
644.70%
Ranking
Category
Stock Price
$25.26
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $18.76B, an increase of 15,664.49%. That is a compound annual growth rate of 64.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 17.79B | 35.22% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |